Liverpool launches high-security robotic AI laboratory

The Liverpool Accelerate Laboratory, a £20 million high-security robotic AI facility, has launched with plans for full operation by 2027. The laboratory aims to accelerate the discovery of drugs and vaccines for high-risk and deadly infectious diseases.

Developed through the Infection Innovation Consortium and supported by £10 million from the Liverpool City Region Life Sciences Innovation Zone programme, the facility will allow industry and academic partners to work with dangerous pathogens using cutting-edge automated technology. The lab will utilize human organoids to provide more accurate indications of treatment impacts compared to traditional animal testing.